title: Does metabolic syndrome influence outcome following percutaneous coronary intervention?
authors.affiliation: Department of Clinical Biochemistry (Vascular Disease Prevention Clinic) and Department of Surgery, Royal Free Campus, UCL Medical School, University College London, London, UK.
authors.forename: Niki
authors.initials: N
authors.lastname: Katsiki
authors.forename: Vasilios G
authors.initials: VG
authors.lastname: Athyros
authors.forename: Dimitri P
authors.initials: DP
authors.lastname: Mikhailidis
mesh_terms: D015906:Angioplasty, Balloon, Coronary; D003327:Coronary Disease / Q000150:complications* / Q000628:therapy*; D003924:Diabetes Mellitus, Type 2 / Q000150:complications; D054855:Drug-Eluting Stents; D006801:Humans; D024821:Metabolic Syndrome / Q000150:complications*; D016896:Treatment Outcome